Pharmacy Benefits and Disease-Modifying Therapies
Feb 17, 2022•3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Daniel Hartung discusses the association between Medicare Part D Plan disease-modifying therapy restrictiveness and adherence and outcomes among people with multiple sclerosis.
Show references:
For the best experience, listen in Metacast app for iOS or Android